NCT06872138View on ClinicalTrials.gov

S100A8 in Serum and Urine as a New Biomarker in Lupus Nephritis

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

March 30, 2025

Study Completion Date

March 30, 2025

Conditions
S100A8SerumUrineBiomarkerLupusNephritis
Trial Locations (1)

12411

Theodor Bilharz Research Institute, Giza

All Listed Sponsors
lead

Theodor Bilharz Research Institute

OTHER

NCT06872138 - S100A8 in Serum and Urine as a New Biomarker in Lupus Nephritis | Biotech Hunter | Biotech Hunter